We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Following encouraging talks with the FDA in July, Amylyx Pharmaceuticals plans to submit a new drug application (NDA) for AMX0035, a compound designed to slow neurodegeneration in amylotropic lateral sclerosis (ALS) patients. Read More
The FDA and the European Medicines Agency (EMA) have launched a pilot program to provide parallel scientific advice to applicants seeking marketing authorization from the EMA for hybrid products and for those filing abbreviated new drug applications (ANDAs) with the FDA for complex generic drugs. Read More
The House Energy and Commerce Committee is marking up a massive $3.5 trillion infrastructure spending package this week that includes provisions aimed at reducing the price of prescription drugs. Read More
COVID-19 vaccine booster shots may be necessary to sustain waning immunity, said Center for Biologics Evaluation and Research (CBER) Director Peter Marks in remarks at the RAPS Convergence annual conference, which is being held virtually this week because of the pandemic. Read More
Gaithersburg, Md.-based Emergent BioSolutions has struck a five-year deal with Providence Therapeutics to help manufacture the Canadian company’s COVID-19 vaccine candidate. Read More
The doctor submitted the results to ClinicalTrials.gov one day after receiving the warning letter, sidestepping a potential fine of at least $10,000 for every day he was in noncompliance. Read More
A federal judge has denied Teva Pharmaceuticals’ motion to dismiss a lawsuit alleging the Israeli drugmaker paid kickbacks to charitable foundations to subsidize Medicare patients’ out-of-pocket payments for its multiple sclerosis drug Copaxone (glatiramer). Read More
A third of the indications for cancer drugs that failed their confirmatory trials after accelerated approval remain on the label for years, with some even getting high endorsements from an alliance of 31 leading oncology centers. Read More